Tag: Highlights
Arena Pharmaceuticals Highlights Strategic Plan Driving Near and Long-term Growth with Eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New I

Arena Pharmaceuticals Highlights Strategic Plan Driving Near and Long-term Growth with Eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New I

- Initiation of etrasimod Ph 2/3 program in Crohn's disease (CD) - Two additional Ph 2 etrasimod development programs in eosinophilic esophagitis (EoE) and alopecia areata ...

Lees verder
Projecties kleuren de Ridderzaal en Mauritshuis: The Hague Highlights

Projecties kleuren de Ridderzaal en Mauritshuis: The Hague Highlights

Ridderzaal en Mauritshuis kleurrijk verlicht met projectieshow The Hague Highlights Donderdag 28 november opende Saskia Bruines, wethouder Onderwijs, Economie & ...

Lees verder
AAIC® 2019 Highlights New Research Showing Healthy Lifestyle May Offset Environmental and Genetic Risk of Alzheimer's Disease

AAIC® 2019 Highlights New Research Showing Healthy Lifestyle May Offset Environmental and Genetic Risk of Alzheimer's Disease

International Conference Also Included Expert Discussion on Role of Infectious Agents in Alzheimer's Disease, and Advances Towards a Blood Test LOS ANGELES, July 17, 2019 ...

Lees verder
The 24th GILF Kicks off to Offer Global Buyers a Feast with 6 Highlights This Autumn

The 24th GILF Kicks off to Offer Global Buyers a Feast with 6 Highlights This Autumn

ZHONGSHAN, China, May 23, 2019 /PRNewswire/ -- Since the first exhibition in 1999, the China (Guzhen) International Lighting Fair (hereinafter GILF) has become a hub of ...

Lees verder
Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton´s Tyrosine Kinase (BTK) Inhibitor to Repor

Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton´s Tyrosine Kinase (BTK) Inhibitor to Repor

Not intended for U.S. media -- 48-week results provide additional evidence of relapse reduction for investigational evobrutinib -- Evobrutinib demonstrated ...

Lees verder
NetComm: IDATE Report Highlights the Challenges ahead in Connecting Everyone

NetComm: IDATE Report Highlights the Challenges ahead in Connecting Everyone

SYDNEY, Nov. 28, 2018 /PRNewswire/ -- The new Connecting Everyone report from French research company IDATE has revealed the real-world challenges in building universal ...

Lees verder
Takeda Highlights Favorable Safety Profile of Entyvio® (vedolizumab) Through Comparative Real-World Data Versus TNFa-Antagonist Therapy in Ulcera

Takeda Highlights Favorable Safety Profile of Entyvio® (vedolizumab) Through Comparative Real-World Data Versus TNFa-Antagonist Therapy in Ulcera

OSAKA, Japan, June 3, 2018 /PRNewswire/ -- Takeda demonstrates leadership in GI by featuring new U.S. VICTORY Consortium data among its 24 sponsored Entyvio abstracts ...

Lees verder
Stryker Highlights Importance of Recognizing Stroke Signs for World Stroke Day

Stryker Highlights Importance of Recognizing Stroke Signs for World Stroke Day

RUEIL-MALMAISON, France, October 26, 2017 /PRNewswire/ -- In honor of World Stroke Day, Stryker reminds the public about the importance of recognizing the signs of a stroke. ...

Lees verder
New Sub-analysis Data Highlights the Benefit of LIXIANA®▼ (edoxaban) Over Warfarin in NVAF Patients According to More Comprehensive Stroke Risk S

New Sub-analysis Data Highlights the Benefit of LIXIANA®▼ (edoxaban) Over Warfarin in NVAF Patients According to More Comprehensive Stroke Risk S

MUNICH, August 29, 2017 /PRNewswire/ -- - Sub-analysis highlights the protective effect of edoxaban against stroke or systemic embolic events (SEEs) and its ...

Lees verder
BizPress.nl